Increased FA binding to HSA, due to elevated FA levels, may contribute to altered insulin signaling dynamics in type 2 diabetes by reducing the capacity of HSA to compete with insulin for Zn2+ binding (6). This evidence concerns the gene ALB and type 2 diabetes mellitus.